FUNCTIONAL BRANDS INC (MEHA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MEHA • US3609481037

0.203 USD
+0 (+2.11%)
At close: Feb 9, 2026
0.2167 USD
+0.01 (+6.75%)
Pre-Market: 2/10/2026, 6:28:50 AM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to MEHA. MEHA was compared to 36 industry peers in the Personal Care Products industry. Both the profitability and financial health of MEHA have multiple concerns. MEHA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • MEHA had negative earnings in the past year.
MEHA Yearly Net Income VS EBIT VS OCF VS FCFMEHA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -500K -1M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.56%, MEHA is doing worse than 72.22% of the companies in the same industry.
  • MEHA has a worse Return On Equity (-365.62%) than 77.78% of its industry peers.
Industry RankSector Rank
ROA -7.56%
ROE -365.62%
ROIC N/A
ROA(3y)-13.18%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MEHA Yearly ROA, ROE, ROICMEHA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • MEHA's Gross Margin of 91.22% is amongst the best of the industry. MEHA outperforms 100.00% of its industry peers.
  • MEHA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MEHA Yearly Profit, Operating, Gross MarginsMEHA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 40 60 80

0

2. Health

2.1 Basic Checks

  • MEHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MEHA has about the same amount of shares outstanding.
  • Compared to 1 year ago, MEHA has a worse debt to assets ratio.
MEHA Yearly Shares OutstandingMEHA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
MEHA Yearly Total Debt VS Total AssetsMEHA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • A Debt/Equity ratio of 2.26 is on the high side and indicates that MEHA has dependencies on debt financing.
  • MEHA has a worse Debt to Equity ratio (2.26) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC16.79%
MEHA Yearly LT Debt VS Equity VS FCFMEHA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -500K -1M

2.3 Liquidity

  • A Current Ratio of 0.61 indicates that MEHA may have some problems paying its short term obligations.
  • MEHA has a Current ratio of 0.61. This is amonst the worse of the industry: MEHA underperforms 86.11% of its industry peers.
  • A Quick Ratio of 0.26 indicates that MEHA may have some problems paying its short term obligations.
  • The Quick ratio of MEHA (0.26) is worse than 86.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.26
MEHA Yearly Current Assets VS Current LiabilitesMEHA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

0

3. Growth

3.1 Past

  • MEHA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.93%, which is quite impressive.
  • Looking at the last year, MEHA shows a decrease in Revenue. The Revenue has decreased by -3.72% in the last year.
EPS 1Y (TTM)54.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-3.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MEHA Yearly Revenue VS EstimatesMEHA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MEHA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MEHA Price Earnings VS Forward Price EarningsMEHA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MEHA Per share dataMEHA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for MEHA!.
Industry RankSector Rank
Dividend Yield 0%

FUNCTIONAL BRANDS INC

NASDAQ:MEHA (2/9/2026, 8:14:49 PM)

Premarket: 0.2167 +0.01 (+6.75%)

0.203

+0 (+2.11%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.42%
Ins Owner Change0%
Market Cap1.43M
Revenue(TTM)6.57M
Net Income(TTM)-559.40K
AnalystsN/A
Price TargetN/A
Short Float %1.49%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 9.33
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.93
BVpS0.02
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.56%
ROE -365.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.22%
FCFM N/A
ROA(3y)-13.18%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 2.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.26
Altman-Z N/A
F-ScoreN/A
WACC16.79%
ROIC/WACCN/A
Cap/Depr(3y)1.66%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-99.19%
OCF growth 3YN/A
OCF growth 5YN/A

FUNCTIONAL BRANDS INC / MEHA FAQ

What is the fundamental rating for MEHA stock?

ChartMill assigns a fundamental rating of 0 / 10 to MEHA.


What is the valuation status of FUNCTIONAL BRANDS INC (MEHA) stock?

ChartMill assigns a valuation rating of 0 / 10 to FUNCTIONAL BRANDS INC (MEHA). This can be considered as Overvalued.


Can you provide the profitability details for FUNCTIONAL BRANDS INC?

FUNCTIONAL BRANDS INC (MEHA) has a profitability rating of 1 / 10.